| 1 |
32536813 |
10.1186/s12935-020-01288-7 |
2022 |
Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. |
RHOA |
| 2 |
33406263 |
10.1093/intimm/dxab002 |
2022 |
CD47 promotes T-cell lymphoma metastasis by up-regulating AKAP13-mediated RhoA activation. |
RHOA |
| 3 |
33567811 |
10.3324/haematol.2020.265991 |
2022 |
Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis. |
RHOA |
| 4 |
33849798 |
10.1016/j.clml.2021.03.002 |
2022 |
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL. |
RHOA |
| 5 |
34390161 |
10.1002/pbc.29285 |
2022 |
Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. |
RHOA |
| 6 |
34426436 |
10.1158/1078-0432.CCR-21-0573 |
2022 |
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma. |
RHOA |
| 7 |
34449978 |
10.1002/dc.24861 |
2022 |
Angioimmunoblastic T-cell lymphoma diagnosed from pleural fluid by integration of morphologic, immunophenotypic, and molecular findings. |
RHOA |
| 8 |
34742294 |
10.1186/s13000-021-01163-7 |
2022 |
Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers. |
RHOA |
| 9 |
35027991 |
|
2022 |
Update on recurrent mutations in angioimmunoblastic T-cell lymphoma. |
RHOA |
| 10 |
35064935 |
10.1111/his.14619 |
2022 |
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. |
RHOA |
| 11 |
35174167 |
10.3389/fcell.2021.806258 |
2022 |
Role of ARHGEF3 as a GEF and mTORC2 Regulator. |
RHOA |
| 12 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
RHOA |
| 13 |
35281533 |
10.1155/2022/7052066 |
2022 |
Effects of BMI1 Gene on Regulating Apoptosis, Invasion, and Migration of HEC-1B Cells Induced by Ionizing Radiation. |
RHOA |
| 14 |
35322197 |
10.1038/s41388-022-02266-1 |
2022 |
Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation. |
RHOA |
| 15 |
35459873 |
10.1038/s41375-022-01571-8 |
2022 |
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. |
RHOA |
| 16 |
35476848 |
10.1182/blood.2021015008 |
2022 |
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma. |
RHOA |
| 17 |
35528192 |
10.1158/2767-9764.crc-21-0022 |
2022 |
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. |
RHOA |
| 18 |
35568648 |
10.1016/j.trecan.2022.04.005 |
2022 |
RHOA takes the RHOad less traveled to cancer. |
RHOA |
| 19 |
35625998 |
10.3390/cancers14102392 |
2022 |
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. |
RHOA |
| 20 |
35639414 |
10.1096/fj.202101808RR |
2022 |
Characterization and computational simulation of human Syx, a RhoGEF implicated in glioblastoma. |
RHOA |
| 21 |
35732446 |
10.2169/internalmedicine.9248-22 |
2022 |
A Case of Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion. |
RHOA |
| 22 |
35848968 |
10.19852/j.cnki.jtcm.20220519.001 |
2022 |
Shenqihuatan formula reduces inflammation by inhibiting transforming growth factor-beta-stimulated signaling pathway in airway smooth muscle cells. |
RHOA |
| 23 |
35868352 |
10.1016/j.virusres.2022.198875 |
2022 |
Signaling factors potentially associated to the pathogenesis of Adult T-cell leukemia /lymphoma: A network-analysis and novel findings assessment. |
RHOA |
| 24 |
35873103 |
|
2022 |
Neoplasms of follicular helper T-cells: an insight into the pathobiology. |
RHOA |
| 25 |
35895386 |
10.1111/bjd.21791 |
2022 |
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. |
RHOA |
| 26 |
35910204 |
10.3389/fgene.2022.948744 |
2022 |
Case Report: Pathogenesis With a Rare <i>RHOA</i> A161E Mutation in a Patient With Angioimmunoblastic T-Cell Lymphoma. |
RHOA |
| 27 |
35921527 |
10.1182/blood.2022015451 |
2022 |
Clonal germinal center B cells function as a niche for T-cell lymphoma. |
RHOA |
| 28 |
35938041 |
10.3389/fgene.2022.940513 |
2022 |
Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma. |
RHOA |
| 29 |
35954378 |
10.3390/cancers14153716 |
2022 |
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma. |
RHOA |
| 30 |
35995702 |
10.1016/j.clml.2022.07.009 |
2022 |
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma. |
RHOA |
| 31 |
36012614 |
10.3390/ijms23169349 |
2022 |
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma. |
RHOA |
| 32 |
36093687 |
10.3233/CBM-220013 |
2022 |
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients. |
RHOA |
| 33 |
31467124 |
10.3324/haematol.2018.210286 |
2021 |
ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients. |
RHOA |
| 34 |
31488561 |
10.3324/haematol.2019.226647 |
2021 |
Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay. |
RHOA |
| 35 |
31870198 |
10.1080/10428194.2019.1702179 |
2021 |
Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for <i>RHOA</i> G17V mutated subtype. |
RHOA |
| 36 |
32476550 |
10.1080/10428194.2020.1768382 |
2021 |
Combination of multicolor flow cytometry for circulating lymphoma cells and tests for the <i>RHOA</i><sup>G17V</sup> and <i>IDH2</i><sup>R172</sup> hot-spot mutations in plasma cell-free DNA as liquid biopsy for the diagnosis of angioimmunoblastic T-cell lymphoma. |
RHOA |
| 37 |
32484856 |
10.1182/bloodadvances.2019001075 |
2021 |
Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma. |
RHOA |
| 38 |
32572934 |
10.26355/eurrev_202006_21535 |
2021 |
Oxycodone inhibits myocardial cell apoptosis after myocardial ischemia-reperfusion injury in rats via RhoA/ROCK1 signaling pathway. |
RHOA |
| 39 |
32648273 |
10.1111/pin.12981 |
2021 |
RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases. |
RHOA |
| 40 |
32923110 |
10.1080/2162402X.2020.1746553 |
2021 |
Angioimmunoblastic T-cell lymphoma-like lymphadenopathy in mice transgenic for human <i>RHOA</i> with p.Gly17Val mutation. |
RHOA |
| 41 |
32945366 |
10.3892/ijmm.2020.4686 |
2021 |
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis. |
RHOA |
| 42 |
33160401 |
10.1186/s13148-020-00962-x |
2021 |
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma. |
RHOA |
| 43 |
33224395 |
10.14740/jh760 |
2021 |
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant <i>De Novo</i> Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor. |
RHOA |
| 44 |
33426772 |
10.1111/cas.14806 |
2021 |
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. |
RHOA |
| 45 |
33496747 |
10.1182/bloodadvances.2020003081 |
2021 |
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma. |
RHOA |
| 46 |
33504766 |
10.1038/s41419-021-03425-0 |
2021 |
The DNA-helicase HELLS drives ALK<sup>-</sup> ALCL proliferation by the transcriptional control of a cytokinesis-related program. |
RHOA |
| 47 |
33546774 |
10.1186/s40164-021-00200-x |
2021 |
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas. |
RHOA |
| 48 |
33650043 |
10.1007/s00428-021-03071-z |
2021 |
Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring. |
RHOA |
| 49 |
33716241 |
10.3960/jslrt.20052 |
2021 |
Follicular T-cell lymphoma mimicking lymphocyte-rich classic Hodgkin lymphoma: a case report of a diagnostic pitfall. |
RHOA |
| 50 |
33739791 |
10.1097/PAS.0000000000001646 |
2021 |
Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. |
RHOA |
| 51 |
33747936 |
10.3389/fonc.2021.622648 |
2021 |
Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. |
RHOA |
| 52 |
33990228 |
10.1186/s40164-021-00224-3 |
2021 |
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas. |
RHOA |
| 53 |
34638508 |
10.3390/cancers13195024 |
2021 |
RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3. |
RHOA |
| 54 |
27898263 |
10.1080/21541248.2016.1263718 |
2020 |
Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas. |
RHOA |
| 55 |
29629950 |
10.1097/PAI.0000000000000644 |
2020 |
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification. |
RHOA |
| 56 |
30373149 |
10.3390/cancers10110402 |
2020 |
Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination. |
RHOA |
| 57 |
30829413 |
10.1002/ajh.25450 |
2020 |
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma. |
RHOA |
| 58 |
30952970 |
10.1038/s41379-019-0254-4 |
2020 |
The pathological features of angioimmunoblastic T-cell lymphomas with IDH2<sup>R172</sup> mutations. |
RHOA |
| 59 |
31013298 |
10.1371/journal.pone.0215765 |
2020 |
Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma. |
RHOA |
| 60 |
31248017 |
10.3390/cells8070646 |
2020 |
RHO Family GTPases in the Biology of Lymphoma. |
RHOA |
| 61 |
31394087 |
10.1016/j.yexmp.2019.104294 |
2020 |
RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment. |
RHOA |
| 62 |
31403034 |
10.3389/fonc.2019.00683 |
2020 |
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. |
RHOA |
| 63 |
31474759 |
10.1038/s41416-019-0557-8 |
2020 |
Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma. |
RHOA |
| 64 |
31594013 |
10.1055/a-0597-7606 |
2020 |
[Current standard in diagnostic and therapy of peripheral T-cell lymphoma]. |
RHOA |
| 65 |
31702703 |
10.1097/PAI.0000000000000683 |
2020 |
High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell Lymphoma Reveals Candidate Pathogenic Mutations. |
RHOA |
| 66 |
31859368 |
10.1002/path.5376 |
2020 |
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell. |
RHOA |
| 67 |
32064593 |
10.1111/bjh.16428 |
2020 |
The new biology of PTCL-NOS and AITL: current status and future clinical impact. |
RHOA |
| 68 |
32104271 |
10.3892/etm.2020.8413 |
2020 |
Fluvastatin protects myocardial cells in mice with acute myocardial infarction through inhibiting RhoA/ROCK pathway. |
RHOA |
| 69 |
32107212 |
10.1158/0008-5472.CAN-19-2787 |
2020 |
Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma. |
RHOA |
| 70 |
32188095 |
10.3390/cancers12030702 |
2020 |
<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30<sup>+</sup> ALK<sup>-</sup> ALCL. |
RHOA |
| 71 |
32271188 |
10.1097/PAS.0000000000001470 |
2020 |
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group. |
RHOA |
| 72 |
32598737 |
10.26442/00403660.2019.07.000330 |
2020 |
[Molecular diagnosis angioimmunoblastic T-cell lymphoma]. |
RHOA |
| 73 |
32637355 |
10.3389/fonc.2020.00898 |
2020 |
Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine. |
RHOA |
| 74 |
33178468 |
10.1155/2020/8890502 |
2020 |
A Rare CD4-CD8+ Adult T-Cell Leukemia/Lymphoma with Unique Molecular Mutations: A Case Report with Literature Review. |
RHOA |
| 75 |
28832024 |
10.1038/leu.2017.273 |
2019 |
Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma. |
RHOA |
| 76 |
29662631 |
10.18632/oncotarget.24592 |
2019 |
Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features. |
RHOA |
| 77 |
29666117 |
10.1182/blood-2017-11-764357 |
2019 |
Novel insights into the pathogenesis of T-cell lymphomas. |
RHOA |
| 78 |
29769264 |
10.1182/blood-2017-11-818617 |
2019 |
RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. |
RHOA |
| 79 |
29877249 |
10.11406/rinketsu.59.574 |
2019 |
[The microenvironment and immune status of peripheral T-cell lymphoma: focusing on AITL and ATLL]. |
RHOA |
| 80 |
29908210 |
10.1016/j.canlet.2018.06.013 |
2019 |
The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling. |
RHOA |
| 81 |
30097855 |
10.1007/s10689-018-0099-x |
2019 |
Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma. |
RHOA |
| 82 |
30413411 |
10.1158/0008-5472.CAN-18-1889 |
2019 |
Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice. |
RHOA |
| 83 |
30631148 |
10.1038/s41388-018-0670-9 |
2019 |
Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting. |
RHOA |
| 84 |
30682817 |
10.3390/cells8020087 |
2019 |
Emerging Roles of Ephexins in Physiology and Disease. |
RHOA |
| 85 |
31594043 |
10.3760/cma.j.issn.0529-5807.2019.10.007 |
2019 |
[Angioimmunoblastic T-cell lymphoma: histopathological grading and prognosis]. |
RHOA |
| 86 |
31597847 |
10.11406/rinketsu.60.1221 |
2019 |
[Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers]. |
RHOA |
| 87 |
28082343 |
10.3324/haematol.2016.158428 |
2018 |
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. |
RHOA |
| 88 |
28272166 |
10.1097/SHK.0000000000000863 |
2018 |
Inhibition of Myosin Light-Chain Kinase Enhances the Clearance of Lipopolysaccharide-Induced Lung Inflammation Possibly by Accelerating Neutrophil Apoptosis. |
RHOA |
| 89 |
28380463 |
10.18632/oncotarget.16559 |
2018 |
Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis. |
RHOA |
| 90 |
28889481 |
10.1111/cas.13393 |
2018 |
Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma. |
RHOA |
| 91 |
29039493 |
10.3892/ijo.2017.4150 |
2018 |
Actein induces apoptosis in leukemia cells through suppressing RhoA/ROCK1 signaling pathway. |
RHOA |
| 92 |
29063178 |
10.1007/s00277-017-3152-1 |
2018 |
Epstein-Barr virus positive diffuse large B cell lymphoma with G17V RHOA mutation arising from peripheral T cell lymphoma, not otherwise specified. |
RHOA |
| 93 |
29279549 |
10.3960/jslrt.17019 |
2018 |
Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma. |
RHOA |
| 94 |
29339730 |
10.1038/s41408-017-0047-2 |
2018 |
Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways. |
RHOA |
| 95 |
29397528 |
10.1007/s11899-018-0432-3 |
2018 |
The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL). |
RHOA |
| 96 |
29398449 |
10.1016/j.ccell.2018.01.001 |
2018 |
RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. |
RHOA |
| 97 |
29493850 |
10.1111/cas.13557 |
2018 |
Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma. |
RHOA |
| 98 |
29769011 |
10.2174/1574892813666180517102801 |
2018 |
Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents. |
RHOA |
| 99 |
30209389 |
10.1038/s41467-018-06134-z |
2018 |
STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas. |
RHOA |
| 100 |
26616858 |
10.1038/onc.2015.442 |
2017 |
Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells. |
RHOA |
Datasets
Models
